Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-039-2 | CAS number: 156324-78-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
No test item-related adverse general effects and adverse reproduction effects were observed up to 300 mg/kg bw/day (NOAEL).
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Based on expert toxicological judgment (see attached document under in section 13 of this technical dossier), an analogue approach for read-across of the endpoint “Screening for reproductive/ developmental toxicity, one species” from the structural analogue to the target substance is considered justified.
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Version / remarks:
- 2016-07-29
- Deviations:
- no
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 300 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: absence of adverse toxic effects
- Key result
- Critical effects observed:
- no
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- > 300 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: absence of adverse toxic effects
- Key result
- Critical effects observed:
- no
- Key result
- Reproductive effects observed:
- no
- Conclusions:
- NOAEL (general toxicity; rat): 300 mg/kg bw/day (actual ingested)
NOAEL (reproduction/developmental toxicity; rat): 300 mg/kg bw/day (actual ingested)
After the oral administration of 30, 100, and 300 mg/kg bw/day of the test item to male and female adult rats, no adverse test item-related effects were observed for clinical signs, mortality, body weight, body weight gain, food consumption, gross pathology, and histopathology. In addition, no test item-related changes were observed for reproductive function and reproductive performance. No test item related changes were observed in the thyroid hormone concentration of adult males. Lastly, no adverse test item-related findings were made in the F1 pup generation, when investigating clinical signs, mortality, body weight, sexual maturation, thyroid hormone concentration, and gross pathology.
Under the experimental conditions of this screening study, the No Observed Adverse Effect Level (NOAEL) for systemic toxicity and reproduction/developmental toxicitywas considered to be 300 mg/kg bw/day (unbound).
Based on expert toxicological judgment (see attached document in section 13 of this technical dossier), an analogue approach for read-across of the endpoint “Screening for reproductive/ developmental toxicity, one species” from the structural analogue (test item) to the target substance is considered justified. - Executive summary:
A toxicity to reproduction study was performed with the test item according to the OECD guideline 421 (2016). The test material was suspended in the vehicle (corn oil) and administered by gavage to three groups, each of twelve male and twelve female Crl: CD(SD) rats, at the dose levels of 30, 100, and 300 mg/kg bw/day. The test item was administered once daily to males and females during two weeks prior to mating and continued through the day before sacrifice in males (at least 50 days), and continued through the lactation day 13 in females. A concurrent control group received the vehicle only. General systemic observations including mortality, general clinical signs, body weights, body weight gain, food consumption, macroscopic findings, organ weights (testis, epididymis, prostate and seminal vesicles only) and microscopic findings (testes, epididymis, and ovaries only) were measured and conducted. In addition, reproductive/developmental observations including oestrus cycle, precoital time, fertility data, reproductive and littering findings, F1 pups clinical signs, body weight, anogenital distance, nipple retention and external examination were conducted. Thyroid hormone level in blood was also analysed for adult males and pups at sacrifice.
After the oral administration of 30, 100, and 300 mg/kg bw/day of the test item to male and female adult rats, no adverse test item-related effects were observed for clinical signs, mortality, body weight, body weight gain, food consumption, gross pathology, and histopathology. In addition, no test item-related changes were determined for reproductive function and reproductive performance. No test item related changes were observed in the thyroid hormone concentration of adult males. Lastly, no adverse test item-related findings were made in the F1 pup generation, when investigating clinical signs, mortality, body weight, sexual maturation, thyroid hormone concentration, and gross pathology.
Under the experimental conditions of this screening study, the No Observed Adverse Effect Levels (NOAELs) for systemic toxicity and reproduction/developmental toxicity were considered to be 300 mg/kg bw/day (unbound).
Read-across approach is considered to be feasible since the structural analogue (test item) and the target substance have negligibly minor differences in structure, properties and transformation pathways.
Reference
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 300 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
In reproductive observations, no test item-related change was observed in estrus cycle, precoital time, fertility data, reproductive and littering findings.n reproductive observations, no test item-related change was observed in estrus cycle, precoital time, fertility data, reproductive and littering findings.
Effects on developmental toxicity
Description of key information
No test item-related adverse developmental effects were observed up to 300 mg/kg bw/day (NOAEL).
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
In developmental observations, no test item-related change was observed in reproductive and littering findings, F1 pups clinical signs, body weight, anogenital distance, nipple retention and external examination.
Justification for classification or non-classification
In a reproductive toxicity screening test (OECD 421) no adverse test item-related effects were observed for clinical signs, mortality, body weight, body weight gain, food consumption, gross pathology, and histopathology. In addition, no test item-related changes were determined for reproductive function and reproductive performance. No test item related changes were observed in the thyroid hormone concentration of adult males. Lastly, no adverse test item-related findings were made in the F1 pup generation, when investigating clinical signs, mortality, body weight, sexual maturation, thyroid hormone concentration, and gross pathology. Under the experimental conditions of this screening study, the No Observed Adverse Effect Levels (NOAELs) for systemic toxicity and reproduction/developmental toxicity were considered to be 300 mg/kg bw/day.
The criteria for classification for the endpoint reproductive toxicity in accordance with regulation 1272/2008 are not met, since no adverse effects on sexual function and fertility and on development were seen.
Based on expert toxicological judgment (see attached document in section 13 of this technical dossier), an analogue approach for read-across of the endpoint “Screening for reproductive/ developmental toxicity, one species” from the structural analogue (test item) to the target substance is considered justified.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.